Barriers to Oral Anticoagulant Use for Stroke Prevention in AF

Slides:

Advertisements

Similar presentations

AF and NOACs An UPDATE JULY 2014

Advertisements

Improving Stroke Prevention in Patients With Atrial Fibrillation.

Antithrombotic Therapy in Atrial Fibrillation Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention of Thrombosis,

Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

1 R1 임준욱 Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation.

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy Dr. Morteza Safi Professor of interventional cardiology Cardiovascular Research.

The patient with atrial fibrillation who needs PCI

When should aspirin be dropped from triple therapy?

You can never be too Thin…. An Update on NOACs

An approach to using risk scores for stroke and bleeding in clinical practice. An approach to using risk scores for stroke and bleeding in clinical practice.

Addressing the Challenges in Primary and Secondary Stroke Prevention

Anticoagulation in Atrial Fibrillation

Covering the Bases in Cardioversion

CHA2DS2-VASc Scoring System General AF Treatment Guidance.

Anticoagulant Safety Remains a Problem Emergency Hospitalizations for Adverse Drug Events.

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

Atrial Fibrillation and PCI

Anticoagulants in Interventional Cardiology:

US Guidelines US Guidelines Low-risk Patients.

NOACs, AF, and PCI: What Do the Latest Data Suggest?

When Is Adding Aspirin to NOACs Worth the Risk?

Access to NOAC Therapy:

Appropriate Stroke Prevention Strategies in Atrial Fibrillation

Nat. Rev. Cardiol. doi: /nrcardio

Introduction ESC Annual Meeting in Review: NOACs and NVAF: Real-World Data, Guidelines, and More.

Advances in Coronary Artery Disease: Moving Beyond Antiplatelet Therapy.

Anticoagulation Highlights From the American Heart Association Meeting 2017.

Up to Date on Which NOAC for Which Patient

New Perspectives in AF and PCI: Implications for the Practicing Physician.

Oral Anticoagulants in AFa,b A Brief History.

Selecting NOACs for High-Risk Patients

Antiplatelet Therapy and Secondary Prevention

NOAC Use in AF: REAL-WORLD Studies WITH REAL RESULTS

Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.

The Essentials for Secondary Stroke Prevention

Assessing the Risk for Stroke in Patients With Atrial Fibrillation

NOACS: Emerging data in ACS/IHD

Efficacy and Safety of Edoxaban in Patients With AF and HF

AF and PCI in Practice.

Access to NOAC Therapy:

Adherence in SPAF: Measures to Improve Care

What Anticoagulant Registries Are Revealing

Learning Objectives Classification of VTE Goals of VTE Treatment.

Oral Anticoagulation in AF

Dos and Don’ts for High-Risk Elderly Patients With AF

Atrial Fibrillation.

Assessing Atrial Fibrillation: Real-World Data vs Clinical Trials

Identifying High-Risk AF Patients

What You Didn't Know About AF and Renal Dysfunction

Cancer-Associated Thrombosis

Improving Outcomes in AF: Do the NOACs Hold Their Promise In The Real World?

Which NOAC and When for Stroke Prevention in AF?

Antithrombotics in Arterial Disease: Focus on Coronary Disease

Improving Adherence to Antiplatelet Therapy After an ACS Event

5 Good Minutes on Atrial Fibrillation-related Stroke

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

Real-World Data in Cardiology: Focus on Atrial Fibrillation

Erratum Canadian Journal of Cardiology

Antithrombotic strategies in patients on long-term oral anticoagulation therapy undergoing percutaneous coronary intervention. ACS: acute coronary syndrome;

Forest plot illustrating the risk ratio of any bleeding and GRADE assessment. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI,

Figure 8. Stroke prevention strategy in patients with AF

Figure 1. Decision-making process of stroke prevention in patients with AF from Asia. The decision-making process includes stroke risk evaluation, OAC.

Forest plot illustrating the risk ratio of major bleeding

Forest plot illustrating the risk ratio of myocardial infarction

Forest plot illustrating risk ratio of stent thrombosis

Antithrombotic Therapy in AF Patients Undergoing PCI

The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.

Can the Dual vs Triple Therapy Controversy in Patients With AF Undergoing PCI Be Put to Rest?

Presentation transcript:

Barriers to Oral Anticoagulant Use for Stroke Prevention in AF

Program Goals

Prevention of Stroke in Patients With AF

PINNACLE: Use of OAC

ESC Guideline Recommendations

Continued Use of Aspirin Is a Barrier to Effective Stroke Prevention

Main Advantages of NOACs Over Warfarin

NOACs vs Vitamin K Antagonists

Barriers to Optimal Anticoagulation

ENGAGE AF Patients at Risk for Falls Have a Greater Benefit in Terms of Lower Bleeding Risk of Edoxaban vs Warfarin

Who Is Being Treated?

CHA2DS2-VASc vs HAS- BLED

Barriers (cont): Creatinine Clearance

Renal Clearance and Dosage Adjustment

Barriers: Reversibility

Elective Interventional Procedures

Patient With AF and Requires PCI

WOEST

Dual vs Triple Therapy in AF Patients Requiring PCI

ESC Recommendations for Combination Therapy With Anticoagulants and Antiplatelets

ENTRUST- AF- PCI Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Barriers: Adherence

Adherence to OAC

Abbreviations

Abbreviations (cont)